Fri. 2 Feb 2024, 7:31am ET
Benzinga
Earnings, News
Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0.78) by 3.85 percent. This is a 1.35 percent decrease over losses of $(0.74) per share from the same period last year. The company reported quarterly sales of $71.50 million which beat the analyst consensus estimate of $67.58 million by 5.80 percent. This is a 31.81 percent increase over sales of $54.24 million the same period last year.